Angelini Group – Product Pipeline Review – Q1 2011 by GlobalMarketsDirect

VIEWS: 11 PAGES: 32

More Info
									   Angelini Group – Product Pipeline Review – Q1 2011
                                                                                          Reference Code: GMDHC1193CDB

                                                                                                Publication Date: MAY 2011




Angelini Group – Product Pipeline Review – Q1 2011                                          GMDHC1193CDB / Published MAY 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Angelini Group – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        3
List of Figures                                                                                                       4
Angelini Group Snapshot                                                                                               5
    Angelini Group Overview                                                                                           5
    Key Information                                                                                                   5
    Key Facts                                                                                                         5
Angelini Group – Research and Development Overview                                                                    6
    Key Therapeutic Areas                                                                                             6
Angelini Group – Pipeline Review                                                                                      9
    Pipeline Products by Stage of Development                                                                         9
    Pipeline Products – Monotherapy                                                                                  10
    Pipeline Products – Combination Treatment Modalities                                                             11
Angelini Group – Pipeline Products Glance                                                                            12
    Angelini Group Clinical Stage Pipeline Products                                                                  12
         Phase II Products/Combination Treatment Modalities                                                          12
    Angelini Group–Early Stage Pipeline Products                                                                     13
         Pre-Clinical Products/Combination Treatment Modalities                                                      13
Angelini Group – Drug Profiles                                                                                       14
    Bindarit                                                                                                         14
         Product Description                                                                                         14
         Mechanism of Action                                                                                         14
         R&D Progress                                                                                                14
    Bindarit + Irbesartan                                                                                            15
         Product Description                                                                                         15
         Mechanism of Action                                                                                         15
         R&D Progress                                                                                                15
    p40 Inhibitor                                                                                                    16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
    AF3473                                                                                                           17
         Product Description                                                                                         17
         Mechanism of Action                                                                                         17
         R&D Progress                                                                                                17
    AF3485                                                                                                           18
         Product Description                                                                                         18
         Mechanism of Action                                                                                         18
         R&D Progress                                                                                                18
    GSK-3ß Inhibitor                                                                                                 19
         Product Description                                                                                         19
         Mechanism of Action                                                                                         19
         R&D Progress                                                                                                19
    MCP-1/CCL2 + Selected CytoKines Productions Inhibitors                                                           20
         Product Description                                                                                         20
         Mechanism of Action                                                                                         20




Angelini Group – Product Pipeline Review – Q1 2011                                        GMDHC1193CDB / Published MAY 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
Angelini Group – Product Pipeline Review



         R&D Progress                                                                                                20
    PPARgamma Modulators                                                                                             21
         Product Description                                                                                         21
         Mechanism of Action                                                                                         21
         R&D Progress                                                                                                21
Angelini Group – Pipeline Analysis                                                                                   22
    Angelini Group – Pipeline Products by Therapeutic Class                                                          22
    Angelini Group - Pipeline Products By Target                                                                     24
    Angelini Group – Pipeline Products by Route of Administration                                                    26
    Angelini Group – Pipeline Products by Molecule Type                                                              27
Angelini Group – Company Statement                                                                                   28
Angelini Group – Locations And Subsidiaries                                                                          29
    Head Office                                                                                                      29
    Other Locations & Subsidiaries                                                                                   29
Financial Deals Landscape                                                                                            30
    Angelini Group Detailed Deal Summary                                                                             30
         Licensing Agreements                                                                                        30
         Recordati Signs Licensing Agreement With Angelini                                                           30
Appendix                                                                                                             31
    Methodology                                                                                                      31
         Coverage                                                                                                    31
         Secondary Research                                                                                          31
         Primary Research                                                                                            31
         Expert Panel Validation                                                                                     32
    Contact Us                                                                                                       32
    Disclaimer                                           
								
To top